In-vitro Toxicology Testing Market Expected to Grow at 13% CAGR Through 2032 | Transparency Market Research

September 13, 2023 04:23 AM AEST | By EIN Presswire
 In-vitro Toxicology Testing Market Expected to Grow at 13% CAGR Through 2032 | Transparency Market Research
Image source: Kalkine Media

In-vitro Toxicology Testing services are anticipated to experience heightened demand due to a multitude of drug development initiatives.

WILMINGTON, DELAWARE, UNITED STATES, September 12, 2023/EINPresswire.com/ -- In-Vitro Toxicity Testing Market has global sales of USD 24.1 billion in 2021. Between 2022 and 2032, the market's value is anticipated to grow at a CAGR of 13%. During the forecast period, the market is expected to offer an absolute dollar potential of USD 64.3 Bn. Significant advancements in the science of toxicity are one of the main industry drivers.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐚 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐩𝐨𝐫𝐭 – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=73510

In-vitro toxicology testing deals with identifying the effects of certain harmful chemicals or medications on organisms. It deals with identifying the toxic abilities of the harmful substance on animals and humans. These substances generally include various agricultural chemicals, therapeutic drugs, and food additives. During the drug discovery process, if any compound is considered a potential candidate, it is first exposed to toxicological studies to identify its toxicity in animals and humans. If the compound passes through toxicology testing, it is then further tested for its pharmacological activities. If the toxic properties of any compound are identified at an initial stage, it can save the lives of many testing animals which are used in later stages of drug development.

The in vitro toxicology testing market is segmented based on the product and service, method, industry, technology, toxicity endpoint & test, and region. Based on product and service, the software segment is projected to witness the highest growth in the in vitro toxicology testing market during the forecast period. Growth in this segment is driven largely by the growing use of assays to make up the basic screening mutagenicity properties of various chemicals and substances.

𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗰 𝗣𝗼𝗶𝗻𝘁𝘀 𝗖𝗼𝘃𝗲𝗿𝗲𝗱:

To study and analyze the global market size (value & volume) by company, key regions/countries, products and application, history data, and forecast to 2032.

To understand the structure of market by identifying its various sub segments.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

Focuses on the key global manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the growth trends, future prospects, and their contribution to the total market.

To project the value and volume of submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

𝐄𝐧𝐪𝐮𝐢𝐫𝐞 𝐁𝐞𝐟𝐨𝐫𝐞 𝐁𝐮𝐲𝐢𝐧𝐠 𝐭𝐡𝐞 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐫𝐞𝐩𝐨𝐫𝐭 𝐟𝐨𝐫 𝐯𝐢𝐭𝐚𝐥 𝐮𝐧𝐝𝐞𝐫𝐬𝐭𝐚𝐧𝐝𝐢𝐧𝐠𝐬- https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=73510

𝗥𝗲𝗴𝗶𝗼𝗻𝗮𝗹 𝗔𝗻𝗮𝗹𝘆𝘀𝗶𝘀:

North America (USA, Canada and Mexico)

Europe (UK, Germany, France and the Rest of Europe)

Asia Pacific (China, Japan, India, and the Rest of the Asia Pacific region)

South America (Brazil, Argentina and the Rest of South America)

Middle East and Africa (GCC and Rest of the Middle East and Africa)

𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 𝐏𝐫𝐞𝐬𝐞𝐧𝐭 𝐢𝐧 𝐭𝐡𝐞 𝐌𝐚𝐫𝐤𝐞𝐭

Merck KGaA

Charles River

Bio-Rad Laboratories, Inc.

Abbott

Thermo Fisher Scientific Inc.

Catalent, Inc.

GE Healthcare

Quest Diagnostics Incorporated

Eurofins Scientific

Laboratory Corporation of America Holdings

Evotec

Creative Bioarray

Gentronix

BioIVT

SGS SA

Agilent Technologies

𝗜𝗻-𝘃𝗶𝘁𝗿𝗼 𝗧𝗼𝘅𝗶𝗰𝗼𝗹𝗼𝗴𝘆 𝗧𝗲𝘀𝘁𝗶𝗻𝗴 𝗠𝗮𝗿𝗸𝗲𝘁 𝗥𝗲𝗽𝗼𝗿𝘁 𝗛𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀

Due to the rising demand for precise and affordable analysis, the cell culture segment had the highest revenue share in terms of technology. Additionally, the use of 3D cell culture is fueling this sector's expansion.

Based on application, the market for in-vitro toxicology testing was dominated by the system toxicology industry. The development of toxicology data points, including the lowest dose, the tolerated dose, the risk assessment, and many others, will help to increase revenue.

Due to advancements in label-free detection, high throughput screening, and cell-based imaging assays, the cellular assays segment had the biggest revenue share.

The largest revenue contribution to the market came from the pharmaceutical industry as an end-user. Due to the huge number of products in the pipeline and the significance of toxicity testing during the drug development phases, revenue is generated.

Due to widespread bans on animal testing and government measures supporting toxicological research, North America accounted for the biggest revenue share. Additionally, the gathering of participants in this region to offer in-vitro testing goods and services will maintain revenue development during the estimate.

𝐇𝐚𝐯𝐞 𝐀𝐧𝐲 𝐐𝐮𝐞𝐫𝐲? 𝐀𝐬𝐤 𝐎𝐮𝐫 𝐄𝐱𝐩𝐞𝐫𝐭𝐬: https://www.transparencymarketresearch.com/sample/sample.php?flag=ASK&rep_id=73510

𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧

𝗕𝘆 𝗠𝗲𝘁𝗵𝗼𝗱

Cellular Assay

Biochemical Assay

In-Silico

Ex-vivo

𝗕𝘆 𝗘𝗻𝗱-𝘂𝘀𝗲

Pharmaceutical Industry

Cosmetics & Household Products

Academic Institutes and Research Laboratories

Diagnostics

Chemical Industry

Food Industry

𝗕𝘆 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆

Cell Culture Technology

High Throughput Technology

Molecular Imaging

OMICS Technology

𝗕𝘆 𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻

Systemic Toxicology

Dermal Toxicity

Endocrine Disruption

Ocular Toxicity

Other Applications

𝐁𝐫𝐨𝐰𝐬𝐞 𝐌𝐨𝐫𝐞 𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐓𝐫𝐚𝐧𝐬𝐩𝐚𝐫𝐞𝐧𝐜𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡-

Facial Prosthetics Market Projected to Reach US$ 1.9 Bn by 2023 with Remarkable 6.8% CAGR

Cold Plasma Market Projected to Surge at 12.3% CAGR, Reaching USD 6.2 Bn by 2031

Nikhil Sawlani
Transparency Market Research Inc.
+ +1 518-618-1030
email us here
Visit us on social media:
Twitter
LinkedIn
YouTube


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.